Antiphospholipid Syndrome and Libman-Sacks Endocarditis in a Bioprosthetic Mitral Valve

Eric H Sladek; Kevin D Accola

doi:10.1016/j.athoracsur.2015.06.113

Antiphospholipid Syndrome and Libman-Sacks Endocarditis in a Bioprosthetic Mitral Valve

Ann Thorac Surg. 2016 Feb;101(2):e29-31. doi: 10.1016/j.athoracsur.2015.06.113.

Authors

Eric H Sladek¹, Kevin D Accola²

Affiliations

¹ Graduate Medical Education, Internal Medicine Residency Program, Oak Hill Hospital, Brooksville, Florida.
² Cardiovascular Institute, Florida Hospital, Orlando, Florida. Electronic address: [email protected].

PMID: 26777966
DOI: 10.1016/j.athoracsur.2015.06.113

Abstract

This report describes one the first cases of antiphospholipid syndrome and Libman-Sacks endocarditis in a bioprosthetic valve. A redo mitral valve replacement was carried out owing to early deterioration of the prior valve. Initially it was considered secondary to rheumatic heart disease; however, pathology analysis and autoimmune workup revealed antiphospholipid syndrome with Libman-Sacks endocarditis. We believe certain populations with mitral valve stenosis may have an underlying antiphospholipid syndrome. As a result, there needs to be a lower threshold for identifying this disease.

Publication types

Case Reports

MeSH terms

Adult
Antiphospholipid Syndrome / complications*
Bioprosthesis*
Endocarditis / complications*
Endocarditis / surgery
Heart Valve Prosthesis*
Humans
Male
Mitral Valve / surgery*
Postoperative Complications* / surgery
Reoperation